Effects of Time, Dose, and Inversion Time for Acute Myocardial Infarct Size Measurements Based on Magnetic Resonance Imaging-Delayed Contrast Enhancement
Authors:
- Raymond J. KimRKRaymond J. Kim
- Robert M. JuddRJRobert M. Judd
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- How We Perform Delayed Enhancement ImagingJournal of Cardiovascular Magnetic Resonance, 2003
- Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging studyThe Lancet, 2003
- Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance ImagingCirculation, 2002
- Imaging Time After Gd-DTPA Injection Is Critical in Using Delayed Enhancement to Determine Infarct Size Accurately With Magnetic Resonance ImagingCirculation, 2001
- Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarctionThe Lancet, 2001
- An Improved MR Imaging Technique for the Visualization of Myocardial InfarctionRadiology, 2001
- The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial DysfunctionNew England Journal of Medicine, 2000
- Contrast-enhanced magnetic resonance imaging of myocardium at riskJACC, 2000
- Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile FunctionCirculation, 1999
- Comparing methods of measurement: why plotting difference against standard method is misleadingThe Lancet, 1995